Literature DB >> 6811965

Ventral root depolarization and spinal reflex augmentation by a TRH analog in rat spinal cord.

H Ono, H Fukuda.   

Abstract

The experiments were performed on spinal rats transected at the C 1 level. Intravenous administrations of TRH and its analog DN-1417 (gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide), which has less endocrine activity, produced a marked increase in the monosynaptic reflex (MSR) and depolarization of the ventral root, without affecting the dorsal root reflex (DRR) and the resting potential of the dorsal root. Excitation of the monosynaptic reflex was not antagonized by chlorpromazine, haloperidol, atropine or cyproheptadine, and was not influenced by pretreatment with reserpine. The depolarization of the ventral root persisted in the presence of baclofen or tetrodotoxin. These findings suggest that depolarization of the ventral root induced by TRH and DN-1417 is due to a direct action on motoneuronal membranes, and that an increase in the monosynaptic reflex is in part due to a depolarization of motoneurones. The effect of DN-1417 were longer lasting than those of TRH.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811965     DOI: 10.1016/0028-3908(82)90058-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.

Authors:  M Tanabe; Y Tokuda; K Takasu; K Ono; M Honda; H Ono
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

2.  Short-term stability of single motor unit recordings in motor neuron disease: a macro EMG study.

Authors:  R J Guiloff; H Modarres-Sadeghi; E Stålberg; H Rogers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

3.  Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).

Authors:  R J Guiloff; E Stålberg; D J Eckland; S L Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

4.  Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.

Authors:  S Nishino; J Arrigoni; J Shelton; T Kanbayashi; W C Dement; E Mignot
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

Review 5.  Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.

Authors:  P J Shaw; C J Eggett
Journal:  J Neurol       Date:  2000-03       Impact factor: 4.849

6.  Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.

Authors:  K A Clarke; G Stirk
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

7.  Down-regulation of thyrotropin-releasing hormone (TRH) receptors in spinal cord after transection as revealed by quantitative autoradiography.

Authors:  G Vita; C K Haun; E F Hawkins; W K Engel
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

8.  Further studies on the action of 5-hydroxytryptamine on lumbar motoneurones in the rat isolated spinal cord.

Authors:  D I Wallis; L A Connell; Z Kvaltinova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

9.  Different spinal effects of opioid agonists on spinal and spino-bulbo-spinal reflexes in rats.

Authors:  T Suzuki; N Nagano; H Ono; H Fukuda
Journal:  J Neural Transm Gen Sect       Date:  1990
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.